Clinical Trial Update: Chidamide + R-GemOx Regimen as Salvage Treatment for Transplant-ineligible Patients With Relapsed/Refractory DLBCL [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating chidamide plus R-GemOx as salvage therapy for transplant-ineligible patients with relapsed/refractory diffuse large B-cell lymphoma (DL…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Chidamide (chidamide)
• R-GemOx (rituximab, gemcitabine, oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lymphoma, Large B-Cell, Diffuse | Phase 2 | Status: COMPLETED